Product Images Linezolid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Linezolid NDC 55150-242 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph depicting the plasma concentration of Linezolid in mcg/mL over a period of 12 hours after oral administration of 600mg every 12 hours. The x-axis measures the time in hours after administration, from 0 to 12 hours, while the y-axis measures the plasma concentration in mcg/mL, ranging from 4 to 12 mcg/mL.*
This is a sterile medication product for intravenous administration consisting of Linezolid, dextrose, sodium citrate, citric acid, and water for injection. It comes in a 300 mL single-dose container with a concentration of 2mg/mL with a strength of 600mg per 300 mL. It is not recommended to add any other medication, and it can only be used with a calibrated infusion device. The solution may exhibit a yellow color that intensifies over time, but it should not affect its potency. This medication requires refrigeration under specific temperature conditions and must not be frozen. The product is manufactured in India and distributed by a company based in New Jersey.*
This is a description for a medication called Linezolid, in the form of an injection, with a concentration of 600 mg per 300 mL. It is produced by a company called AUROMEDIC, and is meant for intravenous administration only. The medication comes in a single-dose container and should not be used in series connections. The container must be checked for leaks prior to usage. The prescription dosage should be followed as additional medications are not recommended. The medication should be stored at 20-25 degrees Celsius and the overwrap should be retained prior to use.*
This is a description of a medication called Linezolid. It is provided in single-dose containers containing 600mg per 300 mL, to be administered intravenously using a calibrated infusion device. The medication must be stored at 20°-25°C, and it is important to protect it from light before use. The accompanying prescribing information should be consulted to determine the proper dosage. The medication should not be used in series connections and supplementary medications should not be added. Checking for leaks is important, and if leaks are found, the medication should be discarded. The medication is distributed by AuroMedics Pharma LLC and produced in India.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.